Invitrogen Corporation (Invitrogen) is a developer, manufacturer and marketer of research tools in reagent, kit and high-throughput applications forms to customers engaged in life sciences research, drug discovery, diagnostics and the commercial manufacture of biological products. The... more

Genentech, Inc. (Genentech) is a biotechnology company that discovers, develops, manufactures and commercializes pharmaceutical products to treat patients with unmet medical needs. It commercializes multiple biotechnology products and also receives royalties from companies that are... more

Genzyme Corporation is a biotechnology company. The Company operates in six units. Renal develops, manufactures and distributes products that treat patients suffering from renal diseases, including chronic renal failure. Therapeutics develops, manufactures and distributes therapeutic... more

Elan Corporation, plc (Elan) is a neuroscience-based biotechnology company. Its operations are organized into two business units: Biopharmaceuticals and Elan Drug Technologies (EDT). Biopharmaceuticals engages in research, development and commercial activities primarily areas, such as... more

Biogen Idec Inc. is engaged in the development, manufacturing, and commercialization of therapies. The Company’s products address diseases such as multiple sclerosis, lymphoma and rheumatoid arthritis. The Company has four products: AVONEX (interferon beta-1a), RITUXAN (rituximab),... more

Incyte Corporation (Incyte) is a drug discovery and development company focused on developing small molecule drugs to treat serious unmet medical needs. The Company has a pipeline with programs in oncology, inflammation, diabetes and human immunodeficiency virus (HIV). Its pipeline... more

Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the field of regenerative medicine. The Company's business is focused on both the development and commercialization of embryonic stem (ES)... more

Serono is a global biotechnology leader. The Company has seven recombinant products, Rebif®, Gonal-F®, Luveris®, Ovidrel®/Ovitrelle®, Serostim®, Saizen® and Zorbtive (Luveris® is not approved in the USA). In addition to being the world leader in reproductive health, Serono has strong... more

Applied Biosystems Inc. (Applied Biosystems) is engaged in the development and marketing of instrument-based systems, consumables, software, and services for academic research, the life science industry and commercial markets. It commercializes technology solutions for deoxyribonucleic... more

Exelixis, Inc. is a biotechnology company engaged in the development of differentiated pharmaceutical products for the treatment of cancer and other serious diseases. Exelixis has a pipeline of compounds in various stages of development that will potentially treat cancer, renal disease... more

Myriad Genetics, Inc. is a healthcare company focused on the development and marketing of molecular diagnostic and therapeutic products. The Company’s molecular diagnostic business focuses on the analysis of genes and their alterations to assess an individual’s risk for developing disease... more

Celera Corporation (Celera) is a healthcare business delivering personalized disease management through a combination of products and services. The Company operates in three segments: a clinical laboratory testing service business (Lab Services), a products business (Products), and a... more

SemBioSys Genetics Inc. is a biotechnology company developing insulin and other protein-based pharmaceuticals for metabolic and cardiovascular diseases. The Company’s lead candidate, produced in the plant host safflower, are recombinant human insulin (insulin) to serve the global diabetes... more

Human Genome Sciences (HGS) is a commercially focused biopharmaceutical company. The Company has three products in late-stage clinical development: Albuferon for chronic hepatitis C, LymphoStat-B for systemic lupus erythematosus and ABthraxtm for inhalation anthrax. All three of these... more

QIAGEN N.V. (QIAGEN) is a provider of technologies and products for preanalytical sample preparation and linked molecular assay solutions. The Company also supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics. Products are sold to academic research... more

ViaCell, Inc., a wholly owned subsidiary of PerkinElmer, is dedicated to enabling the widespread application of human cells as medicine. The Company markets ViaCord®, a product offering through which families can preserve their baby's umbilical cord blood at the time of birth for possible... more

Morphotek(R), Inc., a subsidiary of Eisai Co., Ltd., is a biopharmaceutical company specializing in the development of protein and antibody products through the use of a novel and proprietary gene evolution technology. The technology has been successfully applied to a broad variety of... more

Sequenom, Inc. is a genetics and molecular diagnostic company providing genetic analysis products and services and developing diagnostic tests initially targeted at non-invasive prenatal genetic disorders. The Company's genetic analysis business provides applications that translate... more

Gene Logic, headquartered in Gaithersburg, Md., has developed proprietary genomics databases and services to enable customers worldwide to discover and prioritize drug targets, identify biomarkers, predict toxicity, understand mechanisms of toxicity, and obtain insights into the efficacy... more

A: EraGen was founded in 1994 as Sulfonics, Inc., a California corporation. It changed its name to EraGen Biosciences and was reincorporated in Delaware in 1999. In 2002 the company consolidated its operations from Florida to new facilities in Madison, Wisconsin. Q: How large is EraGen?... more

Affymetrix, Inc. is engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets. The markets for the Company’s products include all aspects of molecular biology research in the life... more

Lexicon Pharmaceuticals, Inc. (Lexicon) is a biopharmaceutical company focused on discovering and developing treatments for human disease. The Company uses its proprietary gene knockout technology to identify and develop new drugs. In its Genome5000 program, Lexicon is utilizing its... more

Pluristem is a leading biopharmaceutical company developing, producing and marketing stem cell products for cell regenerative therapy. Pluristem's platform for expanding stem cells offers breakthrough technology and multiple product opportunities in many therapeutic areas.

Maxygen, Inc. (Maxygen), incorporated on May 7, 1996, is a biotechnology company involved in the discovery and development of next-generation protein pharmaceuticals for the treatment of disease and serious medical conditions. As of December 31, 2007, the Company had three of its... more

GeneGo is a leading provider of data mining & analysis solutions in systems biology. Our data mining tools and databases help to capture and define the underlying biology behind different types of high-throughput experimental data and understand the effects of small molecule drug... more

Targeted Genetics Corporation (Targeted Genetics) is a clinical-stage biotechnology company. The Company is engaged in developing and commercializing therapeutic products called gene therapeutics. The product candidate is being developed as a treatment for inflammatory arthritis, and... more

Agencourt Bioscience Corporation, a wholly owned subsidiary of Beckman Coulter, Inc., is a trusted provider of genomic services and sample preparation products. Our products and services are based on our patented Agencourt® SPRI® technology. Located in Beverly Massachusetts, Agencourt is... more

Rigel Pharmaceuticals, Inc. (Rigel) is a clinical-stage drug development company that discovers and develops small molecule drugs for the treatment of inflammatory/autoimmune diseases, cancer and viral diseases. The Company's research focuses on intracellular signalling pathways and... more

Entelos, Inc. is engaged in pharmaceutical research and development consulting activities to accelerate drug discovery, development and commercialization. In August 2007, the Company acquired Iconix Biosciences, Inc. During the year ended December 31, 2007, the Company completed the... more

Illumina, Inc. develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function. Using its technologies, the Company provides a line of products and services that serve the sequencing, genotyping and gene expression markets. The Company’s... more

About Compugen. Compugen is a world leader in the development and utilization of advanced computational technologies to model and understand the molecular mechanisms of life. The application of the company's technology has led to the creation of a pipeline of more than 4000 novel human... more

BioMarin Pharmaceutical Inc. (BioMarin) develops and commercializes biopharmaceuticals for serious diseases and medical conditions. Its product portfolio comprises three products and multiple investigational product candidates. Approved products include Naglazyme (galsulfase), Kuvan... more

Cold Spring Harbor Laboratory Press is an internationally renowned publisher of books, journals, and electronic media, located on Long Island, New York. It is a division of Cold Spring Harbor Laboratory, an innovator in life science research and the education of scientists, students, and... more

Genta Incorporated (Genta) is a biopharmaceutical company engaged in pharmaceutical (drug) research and development. The Company focuses on the identification, development and commercialization of drugs for the treatment of cancer and related diseases. Genta’s research portfolio consists... more

Introgen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. The Company is developing product candidates to treat a range of cancers using tumor... more

Ventria Bioscience is uniquely positioned to become a scientific leader in the biopharmaceutical industry. We are dedicated to developing and producing innovative, high value products that enhance and save lives. We have achieved scientific excellence through internal research and... more

Tm Bioscience Corporation is a DNA-based Diagnostics company developing a suite of genetic tests. Tm Bioscience's product pipeline includes tests for genetic mutations related to human disease, pharmacogenetics, and infectious disease. Tm Bioscience has advanced proprietary... more

Athersys, Inc. is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates. In July 2007, the Company initiated a Phase I clinical trial in the United Kingdom with its lead candidate in clinical development, ATHX-105, for the treatment of... more

MaxCyte was founded in 1999 to commercialize flow electroporation technology exclusively from the CBR Institute for Biomedical Research. The technology was intended for clinical use, and the application that had been proposed when the technology was first acquired involved loading 1 liter... more

Seattle Genetics, Inc. is a clinical-stage biotechnology company developing monoclonal antibody-based therapies for the treatment of cancer and autoimmune disease. The Company has a worldwide collaboration agreement with Genentech, Inc. to develop and commercialize the product candidate... more

diaDexus makes a difference by developing innovative products to detect cancer and cardiovascular disease.

Corautus Genetics Inc. is a biopharmaceutical company dedicated to the development and commercialization of innovative gene therapy products for the treatment of cardiovascular and vascular disease. Corautus is currently developing and testing a gene therapy product using the Vascular... more

Dharmacon - the world's technology leader AND leading supplier in RNA interference and siRNA - offers a full range of predesigned RNAi reagents and products. What sets Dharmacon apart? Our technology and our committment to service. Dharmacon's pioneering rational design algorithm is... more

Genome Therapeutics is a biopharmaceutical company focused on the discovery and development of pharmaceutical and diagnostics products. The Company's first product candidate, Ramoplanin, is in a Phase III clinical trial for the prevention of bloodstream infections caused by... more

Serologicals Corporation is a global provider of biological products and enabling technologies, which are essential for the research, development and manufacturing of biologically based life science products. Our products and technologies are used in a wide variety of innovative... more

Ceregene strives to develop and commercialize novel gene-based neurotrophic therapies that restore vitality and function to the nervous system in disorders for which significant unmet medical needs exist, such as Alzheimer's and Parkinson's diseases. Success will be realized through our... more

About ViaGen, Inc. (www.viagen.com): Based in Austin Texas, ViaGen is a global provider of advanced livestock genetic technologies whose unmatched expertise in animal genomics is setting new standards for high quality animals and high quality consumer products. ViaGen's industry-leading... more

Expression Analysis, Inc. (http://www.expressionanalysis.com ) is a full-service microarray genetics testing and analysis organization that provides high-quality genomic processing and data analysis services using Affymetrix GeneChip(R) technology. EA is one of the few U.S.-based... more

Athenix is a leader in agricultural and industrial biotechnology. We are a company of highly motivated, uniquely skilled people. We have rapidly built the infrastructure necessary to discover new genes and to develop them into products that meet real customer needs. Athenix is committed... more

GenoMed's broad-spectrum anti-viral approach was specifically mentioned in BioShield II, recently introduced in the US Senate (see Section 2151 of Senate bill S. 975).